Pfiz­er makes an­oth­er bil­lion-dol­lar in­vest­ment in Eu­rope and ex­pands again in Michi­gan

48 minutes ago
Pharma
Manufacturing

‘Catchy’ de­sign tops big ad buys on­line for grab­bing on­col­o­gists’ at­ten­tion — sur­vey

2 hours ago
Pharma
Marketing

No­var­tis bol­sters Plu­vic­to's case in prostate can­cer with PhI­II re­sults

2 hours ago
Pharma
FDA+

And then there were two: Janssen bows out of Hori­zon takeover ne­go­ti­a­tions

2 hours ago
Deals
Pharma

Gene ther­a­py goes acoustic as ARCH-backed biotech launch­es with ul­tra­sound gene de­liv­ery plat­form

4 hours ago
Financing
Cell/Gene Tx

Ver­tex-part­nered gene ther­a­py biotech Affinia scraps IPO plans

7 hours ago
Financing
Startups

Af­ter M&A fell through, Ther­a­peu­tic­sMD sells hor­mone ther­a­py, con­tra­cep­tive ring for $140M cash plus roy­al­ties

8 hours ago
Deals

Am­gen, years be­hind ri­vals, says PhI obe­si­ty drug shows dura­bil­i­ty signs

Yesterday
R&D
Pharma

Big week for Alzheimer’s da­ta; As­traZeneca buys cell ther­a­py start­up; Dig­i­tal ther­a­peu­tics hits a pay­er wall; and more

2 days ago
Weekly

Gilead spot­lights HIV projects and the com­mu­ni­ty lead­ers dri­ving them in new mi­ni-doc­u­men­tary films

3 days ago
Pharma
Marketing

Bris­tol My­ers, Ab­b­Vie drugs shake up first-line pre­scrib­ing among gas­troen­terol­o­gists — re­port

3 days ago
Pharma
Marketing

In­sta­gram, Tik­Tok so­cial me­dia in­flu­encers lead health­care and phar­ma spon­sor­ships — sur­vey

3 days ago
Pharma
Marketing

Beam's base-edit­ed al­lo­gene­ic CAR-T gets FDA go-ahead af­ter four-month wait

3 days ago
Cell/Gene Tx
FDA+

A fledg­ling biotech goes SPAC route to bankroll can­cer vac­cine, CAR-T and CD47

3 days ago
Financing
Startups

FDA re­jects Y-mAbs’ neu­rob­las­toma drug af­ter tak­ing is­sue with clin­i­cal tri­al de­sign

3 days ago
R&D
FDA+

Pfiz­er backs $60M in­fu­sion in­to Car­rick, teams up on breast can­cer treat­ment

3 days ago
Financing
R&D

Sanofi and Am­gen are bring­ing cash to cov­er the ta­ble stakes for the Hori­zon M&A game

3 days ago
Deals

Sy­neos Health pre­dicts phar­ma trends leap­ing for­ward in 2023 af­ter re­boot year

4 days ago
Pharma
Marketing

Vi­iV dri­ves new cor­po­rate coali­tion in­clud­ing Uber, Tin­der and Wal­mart, aimed at end­ing HIV

4 days ago
Pharma

Pfiz­er and Roivant team up again for an­oth­er 'Van­t', set­ting up an­ti-in­flam­ma­to­ry show­down with Prometheus

4 days ago
Deals
R&D

As com­peti­tors near FDA goal­post, Roche spells out its re­peat Alzheimer's set­back

4 days ago
R&D
Pharma

SQZ Biotech slash­es head­count by 60% as founder/CEO hits ex­it — while Syn­log­ic lays off 25%

4 days ago
People
R&D

Eli Lil­ly’s Alzheimer’s drug clears more amy­loid ear­ly than Aduhelm in first-ever head-to-head. Will it mat­ter?

4 days ago
R&D

Mer­ck sues Johns Hop­kins for li­cens­ing Keytru­da patents in se­cret and in con­flict with re­search col­lab­o­ra­tion

5 days ago
Law
1234 Next page Last page